Ovasave Health Technologies Limited

Based in the UAE, Ovasave Health Technologies Limited specializes in fertility testing and egg freezing services, empowering individuals to manage their reproductive health effectively. Founded in 2022 in Abu Dhabi, United Arab Emirates, Ovasave Health Technologies Limited offers innovative fertility solutions. The company recently raised USD 1. 2 mn in funding on July 17, 2025, from investors including 25madison Ventures, Annex Investments, and Plus Venture Capital.

The company has executed one deal to date. Ovasave provides a comprehensive suite of fertility testing and egg freezing services aimed at helping individuals understand and manage their reproductive health. The company's main offerings include at-home hormone and fertility testing kits, which facilitate blood sample collection via a simple finger prick, and egg freezing services, supported by teleconsultations with qualified physicians. These services are designed for women navigating their reproductive years and those approaching midlife, allowing insights into their ovarian reserve and hormonal health.

By connecting clients with pre-vetted fertility experts, Ovasave aims to empower users with personalized care throughout their fertility journey. The company serves a diverse clientele primarily in urban regions across North America, Europe, and the Middle East, catering to women seeking accessible and affordable reproductive health solutions. Ovasave generates revenue through the direct sale of fertility testing kits and related services, including consultations with fertility advisors. Customers typically purchase these kits at specified prices, such as the AMH test and various hormone tests, which provide valuable insights into their fertility status.

The company offers various pricing plans for its supplements and testing services, which include options for prenatal vitamins and fertility-related products. Transactions occur primarily through a direct-to-consumer model, facilitating straightforward online purchases and service bookings. By focusing on personalized care and comprehensive screening options, Ovasave aims to establish long-term relationships with its clients, fostering repeat business and engagement throughout their reproductive health journeys. In July 2025, Ovasave Health Technologies Limited raised USD 1.

2 mn in funding to expand operations into the Kingdom of Saudi Arabia and the Gulf Cooperation Council region. The company plans to increase corporate partnership coverage and enhance its mobile application features, including menstrual cycle tracking and treatment protocol automation. This funding will support these initiatives as Ovasave aims to broaden its market presence and product offerings.